Role of Intralipid in Management of Organophosphorus Poisoning

NCT04393103 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped no avilable resorces

Conditions

Organophosphorus Poisoning

Interventions

DRUG: Intralipid, 20% Intravenous Emulsion
DRUG: Intravenous Atropine Sulfate

Sponsor

Amani Hassan Abdel-Wahab